• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Investing

Hurricane Milton could reduce Disney earnings, Goldman says

by October 9, 2024
written by October 9, 2024

Projected park closures and disruptions from Hurricane Milton could cut into Walt Disney’s earnings, according to Goldman Sachs analysts.

The firm estimated Tuesday that the hurricane, projected to make landfall in central Florida as soon as Wednesday, could reduce earnings before interest and taxes for Disney’s Parks and Experiences segment by about $150 million to $200 million in its current 2025 fiscal first quarter. Goldman’s estimate would exceed the effect on Disney from Hurricane Irma in 2017, which reduced earnings by about $100 million after the parks were forced to close for two days and some cruise ships were disrupted, according to the firm.

Goldman Sachs reduced its estimate for Disney’s fiscal 2025 earnings per share from $5.22 to $5.14. It also estimated that Disney’s first-quarter domestic attendance would take a hit from the storm, projecting a decline of 6% instead of an earlier estimate of down 2%. The firm’s estimates for Disney’s recently ended fourth quarter largely remained the same, with an outlook for earnings per share of $1.16 and a Parks and Experiences segment operating income of $3.8 billion.

As of Tuesday morning, the storm was around 545 miles southwest of Tampa moving at 12 mph. With sustained winds of 145 mph, the storm dropped down to a Category 4 hurricane and could hit the Florida coast as a Category 3.

The storm is projected to make landfall around the Tampa area, which hasn’t been hit directly by a hurricane since 1921. The storm is then projected to head toward Orlando, where Disney World is located, as it decreases in intensity.

Disney has not made any announcements about potential closures. Spokespeople for Disney did not immediately respond to CNBC’s request for comment on the new earnings estimates.

This post appeared first on NBC NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
next post
RBNZ cuts interest rates by 50 bps to 4.75%

You may also like

Yum Brands begins strategic review for struggling Pizza...

November 5, 2025

Kimberly-Clark to buy Kenvue in $48.7 billion deal

November 3, 2025

Barbie, Monopoly toymakers see bright holiday season despite...

October 29, 2025

Target is eliminating 1,800 corporate jobs as it...

October 24, 2025

X-ray tables, hidden cameras: The tech in rigged...

October 24, 2025

Travis Kelce part of investor group aiming to...

October 24, 2025

Trump’s Argentina beef import plan will harm U.S....

October 23, 2025

Customers sue sneaker company On over shoes that...

October 20, 2025

Giorgio Armani group names longtime executive Giuseppe Marsocci...

October 17, 2025

LendingTree founder and CEO Doug Lebda dies in...

October 15, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!








    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Yum Brands begins strategic review for struggling Pizza Hut chain

      November 5, 2025
    • Kimberly-Clark to buy Kenvue in $48.7 billion deal

      November 3, 2025
    • Barbie, Monopoly toymakers see bright holiday season despite tariff pressure

      October 29, 2025
    • Target is eliminating 1,800 corporate jobs as it looks to reclaim its lost luster

      October 24, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (662)
    • Stock (6,426)

    Latest News

    • Yum Brands begins strategic review for struggling Pizza Hut chain
    • Kimberly-Clark to buy Kenvue in $48.7 billion deal

    Popular News

    • Vital signs improve for English healthcare productivity, think tank says
    • Eli Lilly Alzheimer’s drug donanemab approved in China

    About The Significant deals

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy